Epilepsy in Down Syndrome: Timing, Seizures, and Alzheimer’s Disease
Researchers conducted a multicentre, observational, longitudinal study of 4,804 adults with Down syndrome from seven international cohorts.
Researchers conducted a multicentre, observational, longitudinal study of 4,804 adults with Down syndrome from seven international cohorts.
Researchers systematically reviewed 14 randomized controlled trials involving 516 adults with epilepsy, including adults with drug-resistant focal epilepsy.
This systematic review and meta-analysis compared two procedures for drug-resistant epilepsy caused by MRI-positive focal cortical dysplasia type II (FCD II) or tuberous sclerosis complex (TSC).
Researchers combined results from 12 citations on brivaracetam use in children and adolescents age 18 or younger with epilepsy.
This systematic review examined whether déjà vu, déjà vécu, dreamy states, and reminiscence during focal seizures can help identify the epileptogenic zone.
This multicenter retrospective study reviewed clinical records from 61 people with genetically confirmed Dravet syndrome.
Researchers reviewed records from 163 adults treated at one Danish hospital from 2008 to 2017.
Researchers combined results from 48 studies involving 822 people with Lennox-Gastaut syndrome across 19 countries.
This systematic review and meta-analysis examined neuromodulation treatments for people younger than 18 years with drug-resistant epilepsy.